RLAY R&D Expenses
Relay Therapeutics Inc · R&D Expenses
RLAY R&D Expenses
Latest reported$270.72Mperiod ending
RLAY TTM R&D Expenses ($70.40M → $270.72M)
TTM R&D Expenses
High-resolution chart · PNG
RLAY r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 270,723,000 | |
| 258,137,000 | |
| 261,383,000 | |
| 274,043,000 | |
| 282,400,000 | |
| 310,495,000 | |
| 319,089,000 | |
| 328,510,000 | |
| 333,385,000 | |
| 329,594,000 | |
| 330,018,000 | |
| 319,799,000 | |
| 305,205,000 | |
| 277,515,000 | |
| 246,355,000 | |
| 230,985,000 | |
| 209,059,000 | |
| 316,695,000 | |
| 295,650,000 | |
| 275,158,000 | |
| 254,560,000 | |
| 108,079,000 | |
| 99,157,000 | |
| 90,149,000 | |
| 84,029,000 | |
| 78,760,000 | |
| 70,395,000 |